跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Himbacine
首页
药物
Himbacine
Himbacine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Exo- and diastereo- selective syntheses of himbacine analogs
US 2006247450 A1
申请人: SCHERING CORP
优先权: 2006
CN
US
9 件公开
AN EXO-SELECTIVE SYNTHESIS OF HIMBACINE ANALOGS
CN 105175387 A
申请人: SCHERING CORP
优先权: 2005
CN
US
8 件公开
Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate
US 7687631 B2
申请人: SCHERING CORP
优先权: 2007
CN
US
5 件公开
Synthesis of himbacine analogs
US 2006173189 A1
申请人: SCHERING CORP
优先权: 2006
US
4 件公开
Constrained himbacine analogs as thrombin receptor antagonists
US 2005267155 A1
申请人: CHELLIAH MARIAPPAN V
优先权: 2005
CN
US
3 件公开
Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
US 7888377 B2
申请人: SCHERING CORP
优先权: 2006
CN
US
3 件公开
Substituted bicyclic and tricyclic thrombin receptor antagonists
US 8022088 B2
申请人: SCHERING CORP
优先权: 2006
CN
US
3 件公开
Thrombin Receptor Antagonists Based On The Modified Tricyclic Unit Of Himbacine
US 2008085923 A1
申请人: SCHERING CORP
优先权: 2006
CN
US
2 件公开
Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
US 9340530 B2
申请人: MERCK SHARP & DOHME
优先权: 2013
US
2 件公开
Hydronaphtho[2,3-c]furan derivatives and process for the preparation thereof
US 6392059 B1
申请人: KYORIN SEIYAKU KK
优先权: 2001
US
第 1 / 2 页
上一页
下一页
药物
反馈